Filings For: Starling Oncology, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Starling Oncology, Inc. (STLN) 11/6/2026 6:19:06 AM Small View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Rev: $169,767,000 +24.3% Assets $187,773,000 EPS -$0.13
Starling Oncology, Inc. (STLN) 11/5/2026 5:02:03 PM   View Financials Earnings SEC 3Q 2026 Rev $169,767,000 +24.3% Assets $187,773,000 EPS -$0.13 Export Earnings Model
Starling Oncology, Inc. (STLN) 8/6/2026 4:57:52 PM Small View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $161,282,000 +34.6% Assets $178,233,000 EPS -$0.08
Starling Oncology, Inc. (STLN) 8/6/2026 4:53:45 PM   View Financials Earnings SEC 2Q 2026 Rev $161,282,000 +34.6% Assets $178,233,000 EPS -$0.08 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/8/2026 4:02:07 AM Small View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $147,441,000 +41.2% Assets $168,230,000 EPS -$0.02
Oncology Institute, Inc. (STLN) 5/7/2026 4:19:53 PM   View Financials Earnings SEC 1Q 2026 Rev $147,441,000 +41.2% Assets $168,230,000 EPS -$0.02 Export Earnings Model
Oncology Institute, Inc. (STLN) 4/30/2026 6:41:14 PM   View Proxy SEC Y 2025
Oncology Institute, Inc. (STLN) 3/12/2026 5:01:25 PM Small View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $502,729,000 +27.8% Assets $164,656,000 EPS -$0.54
Oncology Institute, Inc. (STLN) 3/12/2026 4:08:08 PM   View Financials Earnings SEC Y 2025 Rev $141,957,000 +41.6% Assets $164,656,000 EPS -$0.05 Export Earnings Model
Oncology Institute, Inc. (STLN) 1/12/2026 8:02:45 AM   View Financials Earnings (Prelim) SEC Y 2025 Export Earnings Model
Oncology Institute, Inc. (STLN) 11/13/2025 4:25:13 PM Small View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $136,564,000 +36.7% Assets $163,619,000 EPS -$0.14
Oncology Institute, Inc. (STLN) 11/13/2025 4:09:08 PM   View Financials Earnings SEC 3Q 2025 Rev $136,564,000 +36.7% Assets $163,619,000 EPS -$0.14 Export Earnings Model
Oncology Institute, Inc. (STLN) 8/13/2025 5:25:35 PM Small View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $119,802,000 +21.5% Assets $159,798,000 EPS -$0.15
Oncology Institute, Inc. (STLN) 8/13/2025 4:26:59 PM   View Financials Earnings SEC 2Q 2025 Rev $119,802,000 +21.5% Assets $159,798,000 EPS -$0.15 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/14/2025 4:33:42 PM Small View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $104,406,000 +10.3% Assets $164,002,000 EPS -$0.21
Oncology Institute, Inc. (STLN) 5/14/2025 4:28:37 PM   View Financials Earnings SEC 1Q 2025 Rev $104,406,000 +10.3% Assets $164,002,000 EPS -$0.21 Export Earnings Model
Oncology Institute, Inc. (STLN) 3/27/2025 6:07:49 AM   View Proxy SEC Y 2024
Oncology Institute, Inc. (STLN) 3/26/2025 6:13:59 AM Small View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $393,412,000 +21.3% Assets $172,717,000 EPS -$0.71
Oncology Institute, Inc. (STLN) 3/24/2025 7:00:57 AM   View Financials Earnings SEC Y 2024 Rev $100,267,000 +16.9% Assets $172,717,000 EPS -$0.15 Export Earnings Model
Oncology Institute, Inc. (STLN) 11/13/2024 4:43:14 PM Small View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $99,901,000 +21.8% Assets $179,183,000 EPS -$0.18
Oncology Institute, Inc. (STLN) 11/13/2024 4:09:42 PM   View Financials Earnings SEC 3Q 2024 Rev $99,901,000 +21.8% Assets $179,183,000 EPS -$0.18 Export Earnings Model
Oncology Institute, Inc. (STLN) 8/13/2024 4:29:44 PM Small View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $98,578,000 +22.9% Assets $179,602,000 EPS -$0.17
Oncology Institute, Inc. (STLN) 8/13/2024 4:07:49 PM   View Financials Earnings SEC 2Q 2024 Rev $98,578,000 +22.9% Assets $179,602,000 EPS -$0.17 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/22/2024 4:28:50 PM Small View Financials 10-Q/A SEC 1Q 2024 ending: 3/31/2024 Rev: $94,666,000 +24.2% Assets $204,532,000 EPS -$0.22
Oncology Institute, Inc. (STLN) 5/22/2024 4:18:48 PM Small View Financials 10-K/A SEC Y 2023 ending: 12/31/2023 Rev: $324,239,000 +28.4% Assets $209,240,000 EPS -$0.92
Oncology Institute, Inc. (STLN) 5/14/2024 4:38:21 PM Small View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $94,666,000 +24.2% Assets $204,532,000 EPS -$0.22
Oncology Institute, Inc. (STLN) 5/14/2024 4:04:40 PM   View Financials Earnings SEC 1Q 2024 Rev $94,666,000 +24.2% Assets $204,532,000 EPS -$0.22 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/2/2024 4:57:04 PM   View Proxy SEC Y 2023
Oncology Institute, Inc. (STLN) 4/22/2024 4:47:19 PM Small View Financials 10-K/A SEC Y 2023 ending: 12/31/2023 Rev: $324,239,000 +28.4% Assets $209,240,000 EPS -$0.92
Oncology Institute, Inc. (STLN) 4/3/2024 4:02:18 PM   View Presentation SEC 2Q 2024
Oncology Institute, Inc. (STLN) 3/28/2024 6:56:15 AM Small View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $324,239,000 +28.4% Assets $209,240,000 EPS -$0.92
Oncology Institute, Inc. (STLN) 3/27/2024 4:11:01 PM   View Financials Earnings SEC Y 2023 Rev $85,788,000 +20.1% Assets $209,240,000 EPS -$0.21 Export Earnings Model
Oncology Institute, Inc. (STLN) 11/8/2023 4:55:30 PM Small View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $82,035,000 +26.3% Assets $218,353,000 EPS -$0.19
Oncology Institute, Inc. (STLN) 11/8/2023 4:42:06 PM   View Financials Earnings SEC 3Q 2023 Rev $82,035,000 +26.3% Assets $218,353,000 EPS -$0.19 Export Earnings Model
Oncology Institute, Inc. (STLN) 8/10/2023 5:17:28 PM   View Presentation SEC 3Q 2023
Oncology Institute, Inc. (STLN) 8/9/2023 4:39:51 PM Small View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $80,224,000 +31.7% Assets $229,959,000 EPS -$0.19
Oncology Institute, Inc. (STLN) 8/9/2023 6:05:03 AM   View Financials Earnings SEC 2Q 2023 Rev $80,224,000 +31.7% Assets $229,959,000 EPS -$0.19 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/10/2023 4:20:54 PM Small View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Rev: $76,192,000 +38.1% Assets $234,633,000 EPS -$0.33
Oncology Institute, Inc. (STLN) 5/10/2023 4:18:39 PM   View Financials Earnings SEC 1Q 2023 Rev $76,192,000 +38.1% Assets $234,633,000 EPS -$0.33 Export Earnings Model
Oncology Institute, Inc. (STLN) 4/28/2023 4:58:38 PM   View Proxy SEC Y 2022
Oncology Institute, Inc. (STLN) 3/27/2023 5:27:56 PM   View Presentation SEC 1Q 2023
Oncology Institute, Inc. (STLN) 3/17/2023 6:02:29 AM   View Correction SEC Y 2022
Oncology Institute, Inc. (STLN) 3/16/2023 4:38:01 PM Small View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $252,483,000 +24.4% Assets $261,665,000 EPS -$0.21
Oncology Institute, Inc. (STLN) 3/9/2023 4:23:03 PM   View Financials Earnings SEC Y 2022 Rev $71,424,000 +36.6% Assets $261,665,000 EPS -$0.18 Export Earnings Model
Oncology Institute, Inc. (STLN) 11/15/2022 6:21:55 AM   View Presentation SEC Y 2022
Oncology Institute, Inc. (STLN) 11/9/2022 4:35:21 PM Small View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Rev: $64,977,000 +24.3% Assets $283,802,000 EPS -$0.17
Oncology Institute, Inc. (STLN) 11/9/2022 4:09:01 PM   View Financials Earnings SEC 3Q 2022 Rev $64,977,000 +24.3% Assets $283,802,000 EPS -$0.17 Export Earnings Model
Oncology Institute, Inc. (STLN) 8/16/2022 6:10:37 AM   View Presentation SEC 3Q 2022
Oncology Institute, Inc. (STLN) 8/11/2022 4:04:24 AM Small View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Rev: $60,921,000 +22.2% Assets $189,740,000 EPS -$0.06
Oncology Institute, Inc. (STLN) 8/9/2022 8:56:00 PM   View Financials Earnings SEC 2Q 2022 Rev $60,921,000 +22.2% Assets $189,740,000 EPS -$0.06 Export Earnings Model
Oncology Institute, Inc. (STLN) 6/3/2022 9:02:32 AM   View Proxy SEC Y 2021
Oncology Institute, Inc. (STLN) 5/11/2022 6:08:12 AM   View Financials Earnings SEC 1Q 2022 Rev $55,161,000 +13.5% Assets $206,512,000 EPS $0.21 Export Earnings Model
Oncology Institute, Inc. (STLN) 5/10/2022 5:40:36 PM Small View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $55,161,000 +13.5% Assets $206,512,000 EPS $0.21
Oncology Institute, Inc. (STLN) 3/11/2022 4:13:28 PM   View Presentation SEC 1Q 2022
Oncology Institute, Inc. (STLN) 3/11/2022 3:41:43 PM Small View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $203,003,000 Assets $203,439,000 EPS -$0.16
Oncology Institute, Inc. (STLN) 3/10/2022 4:11:13 PM   View Financials Earnings SEC Y 2021 Rev $52,304,000 Assets $203,439,000 EPS -$0.15 Export Earnings Model
Oncology Institute, Inc. (STLN) 12/14/2021 6:11:19 AM Small View Financials 10-Q/A SEC 3Q 2021 ending: 9/30/2021 Rev: $52,275,000 Assets $230,299,733 EPS -$0.05
Oncology Institute, Inc. (STLN) 12/14/2021 6:11:18 AM Micro View Financials 10-K/A SEC Y 2020 ending: 12/31/2020 Assets $65,689,000 EPS -$0.24
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 11/8/2021 5:23:02 PM Small View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Rev: $52,275,000 Assets $230,299,733 EPS -$0.05
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 8/16/2021 4:41:15 PM Small View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $49,844,000 Assets $230,754,006 EPS $0.05
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 5/28/2021 7:51:25 AM Small View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $48,580,000 Assets $203,439,000 EPS -$0.02
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 5/24/2021 6:14:24 AM Micro View Financials 10-K/A SEC Y 2020 ending: 12/31/2020 Assets $65,689,000 EPS -$0.24
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 3/30/2021 5:46:02 PM Micro View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $65,689,000 EPS -$0.24
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 11/13/2020 4:16:06 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 8/13/2020 4:28:12 PM Micro View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020
DFP HEALTHCARE ACQUISITIONS CORP. (STLN) 5/8/2020 4:15:19 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020